Information from the abstract
Background: Syzygium cumini and other Myrtaceae plants are widely used as traditional remedies for dysglycemia, yet clinical evidence remains fragmented and heterogeneous. This study aimed to evaluate the efficacy and safety of S. cumini and related Myrtaceae interventions in individuals with dysglycemia. Methods: A systematic review and meta-analysis of randomized controlled trials was conducted in accordance with PRISMA 2020 and registered in PROSPERO (CRD420261332539). PubMed, Scopus, Embase, MEDLINE, and Web of Science were searched from inception to 3 September 2025. Eligible trials enrolled participants with type 2 diabetes mellitus (T2DM) or prediabetes and evaluated Myrtaceae interventions versus controls. Random-effects meta-analyses were performed to estimate mean differences (MDs) with 95% confidence intervals (CIs). Results: Thirteen trials comprising 802 participants were included. Myrtaceae interventions were associated with a statistically significant but modest reduction in fasting plasma glucose (MD −14.40 mg/dL, 95% CI −23.12 to −5.67; I2 = 98.57%). However, effects on postprandial glucose (MD −12.99 mg/dL, 95% CI −27.74 to 1.76; I2 = 97.93%) and HbA1c (MD −0.46%, 95% CI −0.98 to 0.06; I2 = 99.20%) were not statistically significant. Overall effects on lipid outcomes and laboratory safety markers were also not significant. Subgroup analyses suggested possible variation by participant type, plant part, formulation composition, comparator type, and treatment duration, but these findings were exploratory and accompanied by substantial heterogeneity. Conclusions: Myrtaceae interventions may provide a modest short-term reduction in fasting glycemia among adults with T2DM or prediabetes. However, the clinical significance and generalizability of this finding remain uncertain due to high heterogeneity, short follow-up, absence of low-risk trials, and low to very low certainty of evidence. Current evidence does not support consistent benefits for PPG, HbA1c, lipid outcomes, or long-term safety. These interventions should be considered promising but unproven adjuncts rather than alternatives to standard dysglycemia management.
Why this record is monitored
This record has an Impact Signal of 70/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.
Related topics: Natural Antidiabetic Agents Studies · Diabetes, Cardiovascular Risks, and Lipoproteins · Diabetes Treatment and Management
Thai researcher and institutional participation
Thitinat Duangchan · Kunanya Kuakul · Cholthicha Saipin · Hanna Pongyeela · Hazna Sarana · Moragot Chatatikun · Atthaphong Phongphithakchai · Walailak University · Prince of Songkla University
Data limitations
This page is a bibliographic record based on abstract-level information, not a full analysis or quality assessment. Verify the DOI and original article before citation.